Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06ZZL
|
|||
| Former ID |
DIB003649
|
|||
| Drug Name |
MEDI-500
|
|||
| Synonyms |
T10B9; T10B9.1A31
Click to Show/Hide
|
|||
| Indication | Bone marrow transplantation [ICD-11: QB63.6; ICD-9: 279.5, 996] | Terminated | [1] | |
| Company |
University of Kentucky
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Regulatory protein unspecific (RGP) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006835) | |||
| REF 2 | T10B9 (MEDI-500) mediated immunosuppression: studies on the mechanism of action. Clin Transplant. 1996 Dec;10(6 Pt 2):607-13. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.